These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2007-002531-83 Etude de phase 2 randomisée comparant une irradiation encéphalique associée au témozolomide à une irradiation seule chez des patientes présentant des métastases cérébrales d'un cancer du sein. not-yet-due
Ongoing 2008-001053-18 Étude de phase II randomisée évaluant une irradiation pelvienne associée au Cisplatine seul ou au Cisplatine plus Cetuximab chez des patientes présentant un carcinome du col utérin de stade IB2, II et... not-yet-due
Not reported 2008-005691-27 Etude de phase III randomisée comparant une chimiothérapie adjuvante par Fotémustine à une surveillance chez des patients présentant un mélanome de la choroïde à haut risque de rechute. 2020-06-12 due-trials
Ongoing 2009-011751-46 Etude de phase II monocentrique associant Bevacizumab et Temozolomide chez des patients atteints de mélanome uvéal en première ligne métastatique. not-yet-due
Ongoing 2009-016448-38 Traitement adjuvant dans les rétinoblastomes unilatéraux étendus énucléés d’emblée. not-yet-due
Ongoing 2009-017269-49 Etude de phase II d’évaluation de la toxicité et de l’efficacité d’un traitement par Tacrolimus (Prograf®) chez des patients atteints d’un lymphome diffus à grandes cellules B ou T. not-yet-due
Other 2011-000990-29 Multinational European Trial for Children with the Opsoclonus Myoclonus Syndrome / Dancing Eye Syndrome OMS/DES Ensayo Multinacional Europeo para niños con el Síndrome de Opsoclono Mioclono/ Síndr... not-yet-due
No trial status on register 2011-003621-10 CONSERVATIVE TREATMENT OF PATIENTS WITH RETINOBLASTOMA bad-data
Completed, but no date 2012-003786-17 Phase II study evaluating the efficacy of Lenalidomide in association with Rituximab in refractory or relapse of primary central nervous system lymphoma (PCNSL) - “Proof of concept” bad-data
Ongoing 2013-001432-22 A Multicenter Open label Phase II study of Pomalidomide and Cyclophosphamide and Dexamethasone in relapse/refractory Multiple Myeloma patients who were first treated within the IFM/DFCI 2009 trial ... not-yet-due
Not reported 2014-002752-50 Phase II clinical trial evaluating the efficacy of the dual inhibition of PIK/Akt/mTor signaling pathway by PF-05212384 (PKI-587) for patients with myeloid neoplasm secondary to chemo-radiotherapy (t-... 2017-04-26 due-trials
Ongoing 2015-003806-18 IMPROVEMENT OF LOCAL CONTROL IN SKULL BASE AND SPINE CHORDOMAS TREATED BY SURGERY AND PROTONTHERAPY TARGETING HYPOXIC CELLS REVEALED BY POSITRON EMISSION TOMOGRAPHY NITROIMIDAZOLE ([18F]FAZA) PET/CT T... not-yet-due
No trial status on register 2016-000981-46 First-line treatment of Ewing tumours with primary extrapulmonary dissemination in patients from 2 to 50 years - Traitement de 1ère intention de patients âgés de 2 à 50 ans atteints de tumeur d’Ewi... bad-data
Ongoing 2019-003632-23 LOC-R01: Randomized Phase IB/II Study of escalating doses of Lenalidomide and Ibrutinib in association with R-MPV as a targeted induction treatment for patients aged 18 to 60 with a newly diagnosed Pr... not-yet-due
Ongoing 2019-005039-94 RETINO 2018 : Ocular conservative treatment for retinoblastoma: efficacy of the new management strategies and visual outcome. RETINO 2018 :Traitements conservateurs du rétinoblastome: efficacité de... not-yet-due
Ongoing 2020-004872-17 A Double-blind Randomized non-inferiority Trial of erector spinae block (ESP) versus paravertebral block (PVB) before Breast Cancer Surgery: Effects on acute Postoperative Pain Essai clinique rando... not-yet-due
Ongoing 2022-001139-98 Opioid-Free versus Opioid-Based Anaesthesia for secondary free-flap reconstruction surgery of the breast: A phase III multicentric randomized controlled study Anesthésie sans morphinique versus Ane... not-yet-due